Risk Associated With Statin Treatment

Journal of the American College of Cardiology

Volumn 51, Issue 1, 2008, Pages 91-

  Kjekshus, John ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; PLACEBO; SIMVASTATIN;

ARTERY DISEASE; ATHEROSCLEROSIS; CANCER RISK; CAUSE OF DEATH; CLINICAL TRIAL; CORONARY ARTERY DISEASE; GERIATRIC PATIENT; HEART FAILURE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; LETTER; PRIORITY JOURNAL; PROGNOSIS; SIDE EFFECT; STROKE;

ATHEROSCLEROSIS; CHOLESTEROL, LDL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; NEOPLASMS; RISK FACTORS; TREATMENT OUTCOME;

EID: 37449004201     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.08.056     Document Type: Letter

References (5)

1. Horwich T.B., Hamilton M.A., Maclellan W.R., and Fonarow G.C. Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure. J Card Fail 8 (2002) 216-224
2. Rauchhaus M., Clark A.L., Doehner W., et al. The relationship between cholesterol and survival in patients with chronic heart failure. J Am Coll Cardiol 43 (2003) 1933-1940
3. Corti M.-C., Guralnik J.M., Salive M.E., et al. Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons. Ann Intern Med 126 (1997) 153-160
4. Alsheikh-Ali A.A., Maddukuri P.V., Han H., and Karas R.H. Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer. J Am Coll Cardiol 50 (2007) 409-418
5. Strandberg T.E., Pyörälä K., Cook T.J., et al. Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study. Lancet 364 (2004) 771-777